A conference of the MIT Laboratory for Financial Engineering
In collaboration with the National Cancer Institute
and with the participation of the American Cancer Society
Support from the Alfred P. Sloan Foundation is gratefully acknowledged
June 16-18, 2013
CanceRX is an invitation-only conference that will focus exclusively on new approaches to commercializing biomedical research in oncology through financial engineering. Bringing together representatives from key stakeholder communities—including academia and medical research centers, community hospitals, the biopharma industry, health plans, government agencies, patient advocacy groups, investment banks, hedge funds, credit rating agencies, biotech venture capitalists, and institutional and retail investors—the conference will be organized into six sessions, each focused on a specific aspect of the conference theme:
To encourage free and open discussion throughout the course of the conference, we are invoking the Chatham House Rule. In addition, no invitations have been or will be issued to members of the press.